US2008125580A1PendingUtilityA1
Refolding of Recombinant Proteins
Est. expiryJul 14, 2026(expired)· nominal 20-yr term from priority
C07K 1/1133C07K 1/14C07K 1/16C07K 1/20C07K 1/36C07K 14/00C07K 14/475C07K 1/1136
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Processes are provided for recovering and purifying refolded recombinant proteins produced in heterologous host cells, which includes the step of refolding the protein in a high pH buffer.
Claims
exact text as granted — not AI-modified1 . A process for recovering a refolded recombinant protein from a prokaryotic cell culture, the process comprising the steps of:
(a) isolating a recombinant protein from the prokaryotic cell culture; (b) solubilizing said protein in a first buffered solution, pH greater than 9, comprising a first chaotropic agent; (c) refolding said solubilized protein in a second buffered solution, pH>9 but ≦11, comprising a second chaotropic agent, two or more reducing agents and addition of air or oxygen for such a time and under such conditions that refolding of the recombinant protein occurs; and (d) recovering said refolded recombinant protein.
2 . The process of claim 1 , wherein the recombinant protein is a growth factor.
3 . The process of claim 2 , wherein the growth factor is vascular endothelial growth factor (VEGF).
4 . The process of claim 3 , wherein the VEGF is VEGF 165 .
5 . The process of claim 1 , wherein the first and second chaotropic agents are urea.
6 . The process of claim 1 , wherein the first buffered solution further comprises arginine.
7 . The process of claim 1 , wherein the second buffered solution further comprises arginine.
8 . The process of claim 1 , wherein the first buffered solution comprises 1 M Urea, 300 mM arginine, 10 mM CHES, 5 mM EDTA, pH 1, final concentration.
9 . The process of claim 1 , wherein the first buffered solution comprises 1 M Urea, 300 mM arginine, 10 mM TRIS, 5 mM EDTA, pH 11, final concentration.
10 . The process of claim 1 , wherein the second buffered solution comprises 1 M Urea, 15 mM cysteine, 2 mM DTT, 100 mM arginine, 10 mM CHES, 5 mM EDTA, pH 10, final concentration.
11 . The process of claim 1 , wherein the second buffered solution comprises 1 M Urea, 15 mM cysteine, 0.5-2 mM DTT, 100 mM arginine, 10 mM TRIS, 5 mM EDTA, pH 10, final concentration.
12 . The process of claim 1 , wherein the recombinant protein is incubated in the first buffered solution for at least 1 hour.
13 . The process of claim 12 , wherein the incubation is performed at 2-40° C.
14 . The process of claim 1 , wherein the solubilized protein is incubated in the second buffered solution for about 3 to 24 hours.
15 . The process of claim 14 , wherein the incubation is performed at 2-40° C.
16 . The process of claim 1 , wherein the two or more reducing agents comprises cysteine and DTT.
17 . The process of claim 1 , wherein the addition of air or oxygen is provided at ak La =0.001 to 0.1 min −1 .
18 . The process of claim 1 , further comprising stabilizing the refolded recombinant protein by adding nitrogen.
19 . The process of claim 1 , wherein said recovery step (d) comprises clarifying the second buffered solution with the recombinant protein and sequentially contacting said refolded recombinant protein to a mixed mode chromatographic support, a cationic chromatographic support, and a first hydrophobic chromatographic support, and selectively eluting the refolded recombinant protein from each support.
20 . The process of claim 19 , wherein the clarifying step comprises: adding detergent to a final concentration of 1%, adjusting pH to about 8.5-9.5, incubating solution for 1 to 10 hours at 25-30° C., centrifuging the solution; and filtering liquid recovered from the centrifugation step.
21 . The process of claim 19 , further comprising contacting said refolded recombinant protein to a second hydrophobic chromatographic support or an ion exchange support and selectively eluting the refolded recombinant protein from the support.
22 . The process of claim 19 or 21 , wherein said first and second hydrophobic interaction chromatographic support is selected from the group consisting of butyl-, propyl-, octyl-, phenyl- and aryl-agarose resins.
23 . A process for recovering a refolded recombinant protein from a prokaryotic cell culture, the method comprising the steps of:
(a) isolating a recombinant protein from the prokaryotic cell culture; (b) solubilizing and refolding said protein in a combo buffered solution, pH>9 but ≦11, with addition of air or oxygen; and, (c) recovering said refolded recombinant protein.
24 . The process of claim 23 , wherein the recovery step comprises clarifying the combo solution with the recombinant protein and sequentially contacting said refolded recombinant protein to a mixed mode chromatographic support, a cationic chromatographic support, and a first hydrophobic chromatographic support, and selectively eluting the refolded recombinant protein from each support.
25 . The process of claim 24 , wherein the clarifying step comprises: adding detergent to a final concentration of 1%, adjusting pH to about 8.5-9.5, incubating solution for 1 to 10 hours at 25-30° C., centrifuging the solution; and filtering liquid recovered from the centrifugation step.
26 . The process of claim 23 , wherein the combo buffered solution comprises 1 M Urea, 15 mM cysteine, 2 mM DTT, 100 mM arginine, 10 mM CHES, 5 mM EDTA, pH 10, final concentration.
27 . The process of claim 23 , wherein the combo buffered solution comprises 1 M Urea, 15 mM cysteine, 0.5-2 mM DTT, 100 mM arginine, 10 nM TRIS, 5 mM EDTA, pH 10, final concentration.
28 . The process of claim 23 , wherein the recombinant protein is incubated in the combo buffered solution for about 3 to 24 hours.
29 . The process of claim 28 , wherein the incubation is performed at 2-40° C.
30 . The process of claim 24 , further comprising contacting said refolded recombinant protein to a second hydrophobic chromatographic support or an ion exchange support and selectively eluting the refolded recombinant protein from the support.
31 . A method for purifying a recombinant protein, the method comprising the steps of: sequentially contacting a recombinant protein with a mixed mode support, a cationic chromatographic support, a first hydrophobic interaction chromatographic support, and selectively eluting the recombinant protein from each support.
32 . The method of claim 30 , further comprising contacting the recombinant protein with a second hydrophobic chromatographic support or an ion exchange support, and selectively eluting the recombinant protein from the support.Join the waitlist — get patent alerts
Track US2008125580A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.